DJ Bristol Myers Squibb Co. Stock Underperforms Tuesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. $(BMY)$ shed 3.04% to $58.76 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.92% to 6,067.70 and the Dow Jones Industrial Average rising 0.31% to 44,850.35.
The stock's fall snapped a five-day winning streak.
Bristol Myers Squibb Co. closed 3.83% below its 52-week high of $61.10, which the company reached on January 27th.
The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ fell 1.64% to $150.38, Pfizer Inc. $(PFE)$ fell 0.41% to $26.75, and Abbott Laboratories $(ABT)$ fell 1.58% to $127.39.
Trading volume (9.1 M) remained 1.6 million below its 50-day average volume of 10.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled January 28, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
January 28, 2025 16:38 ET (21:38 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.